Net Cash Provided by (Used in) Financing Activities of MARIZYME, INC. from 30 Jun 2010 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
MARIZYME, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2010 to 31 Mar 2024.
  • MARIZYME, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $666,632, a 29% decline year-over-year.
  • MARIZYME, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,322,435, a 41% decline from 2022.
  • MARIZYME, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $7,290,674, a 4.8% increase from 2021.
  • MARIZYME, INC. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $6,956,672, a 11% increase from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

MARIZYME, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $666,632 -$272,464 -29% 01 Jan 2024 31 Mar 2024 10-Q 28 May 2024 2024 Q1
Q1 2023 $939,096 -$2,475,276 -72% 01 Jan 2023 31 Mar 2023 10-Q 28 May 2024 2024 Q1
Q1 2022 $3,414,372 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2020 $0 $0 01 Jan 2020 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q1 2019 $0 $0 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q1 2018 $0 +$16,000 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q1 2017 $16,000 -$16,000 01 Jan 2017 31 Mar 2017 10-K/A 27 Jun 2018 2017 FY
Q1 2016 $0 01 Jan 2016 31 Mar 2016 10-K/A 27 Jun 2018 2017 FY
Q1 2013 $4,882,141 -$4,872,145 -48741% 01 Jan 2013 31 Mar 2013 10-Q/A 15 Aug 2013 2013 Q1
Q2 2012 $521,180 +$599,832 +54% 01 Apr 2012 30 Jun 2012 10-Q/A 13 Sep 2012 2012 Q1
Q1 2012 $9,996 01 Jan 2012 31 Mar 2012 10-Q/A 15 Aug 2013 2013 Q1
Q2 2011 $1,121,012 -$255,906 -30% 01 Apr 2011 30 Jun 2011 10-Q/A 13 Sep 2012 2012 Q1
Q2 2010 $865,106 01 Apr 2010 30 Jun 2010 10-Q/A 23 Mar 2012 2011 Q1

MARIZYME, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $4,322,435 -$2,968,239 -41% 01 Jan 2023 31 Dec 2023 10-K/A 06 Feb 2025 2023 FY
2022 $7,290,674 +$334,002 +4.8% 01 Jan 2022 31 Dec 2022 10-K/A 06 Feb 2025 2023 FY
2021 $6,956,672 +$681,508 +11% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
2020 $6,275,164 +$6,150,164 +4920% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $125,000 -$43,785 -26% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2021 2020 FY
2018 $168,785 -$546,633 -76% 01 Jan 2018 31 Dec 2018 10-K 15 Apr 2020 2019 FY
2017 $715,418 +$878,415 01 Jan 2017 31 Dec 2017 10-K 05 Mar 2019 2018 FY
2016 $162,997 -$465,389 -154% 01 Jan 2016 31 Dec 2016 10-K/A 28 Nov 2018 2017 FY
2015 $302,392 -$167,099 -36% 01 Jan 2015 31 Dec 2015 10-K/A 28 Nov 2018 2017 FY
2014 $469,491 +$2,964,628 01 Jan 2014 31 Dec 2014 10-K/A 28 Nov 2018 2017 FY
2013 $2,495,137 -$5,696,872 -178% 01 Jan 2013 31 Dec 2013 10-K/A 28 Nov 2018 2017 FY
2012 $3,201,735 -$9,527,083 -75% 01 Jan 2012 31 Dec 2012 10-K/A 28 Nov 2018 2017 FY
2011 $12,728,818 +$13,751,866 01 Jan 2011 31 Dec 2011 10-K/A 08 May 2014 2012 FY
2010 $1,023,048 01 Jan 2010 31 Dec 2010 10-K/A 31 Mar 2014 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.